Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy

NCT01512446 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

436

Enrollment

INDUSTRY

Sponsor class

Stopped low recruitment rate

Conditions

Osteoporosis

Interventions

DRUG: Alendronate
DRUG: Placebo

Sponsor

Evangelisches Krankenhaus Lutherhaus gGmbH

Collaborators

[object Object]